Literature DB >> 26855153

Pre-transplant diastolic but not systolic dysfunction has a negative prognostic impact after allogeneic stem cell transplantation.

M Sarmiento1,2, R Parody1, F Márquez-Malaver1, I Espigado1, J Falantes1, T Caballero1, C Calderón1, M Carmona1, J López Haldon3, J A Pérez-Simón1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26855153     DOI： 10.1038/bmt.2016.8

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

Review 1.  Impacts of pretransplant comorbidities on allogeneic hematopoietic cell transplantation (HCT) outcomes.

Authors:  Mohammed Sorror
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

2.  Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation.

Authors:  Per Ljungman; Ronald Brand; Jennifer Hoek; Rafael de la Camara; Catherine Cordonnier; Hermann Einsele; Jan Styczynski; Katherine N Ward; Simone Cesaro
Journal:  Clin Infect Dis       Date:  2014-05-20       Impact factor: 9.079

Review 3.  The EBMT risk score.

Authors:  A Gratwohl
Journal:  Bone Marrow Transplant       Date:  2011-06-06       Impact factor: 5.483

Review 4.  Strategies to prevent and treat cardiovascular risk in cancer patients.

Authors:  Daniela Cardinale; Giulia Bacchiani; Marta Beggiato; Alessandro Colombo; Carlo M Cipolla
Journal:  Semin Oncol       Date:  2013-04       Impact factor: 4.929

5.  Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens.

Authors:  A C Braverman; J H Antin; M T Plappert; E F Cook; R T Lee
Journal:  J Clin Oncol       Date:  1991-07       Impact factor: 44.544

6.  Hematopoietic stem cell transplantation in autoimmune diseases: algorithm for cardiovascular assessment.

Authors:  Irene Miniati; Maria Letizia Conforti; Pasquale Bernardo; Alan Tyndall; Gian Franco Gensini; Marco Matucci-Cerinic
Journal:  Herz       Date:  2007-02       Impact factor: 1.443

7.  Hematopoietic stem cell transplantation in patients with systolic dysfunction: can it be done?

Authors:  Peter Hurley; Suma Konety; Qing Cao; Daniel Weisdorf; Anne Blaes
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-16       Impact factor: 5.742

8.  Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies).

Authors:  Xavier Bosch; Montserrat Rovira; Marta Sitges; Ariadna Domènech; José T Ortiz-Pérez; Teresa M de Caralt; Manuel Morales-Ruiz; Rosario J Perea; Mariano Monzó; Jordi Esteve
Journal:  J Am Coll Cardiol       Date:  2013-04-10       Impact factor: 24.094

Review 9.  Cardiac assessment of patients for haematopoietic stem cell transplantation.

Authors:  J G Coghlan; C E Handler; P D Kottaridis
Journal:  Best Pract Res Clin Haematol       Date:  2007-06       Impact factor: 3.020

Review 10.  Causes and pathophysiology of heart failure with preserved ejection fraction.

Authors:  Árpád Kovács; Zoltán Papp; László Nagy
Journal:  Heart Fail Clin       Date:  2014-05-22       Impact factor: 3.179
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.